Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical (LFCR) Shares Outstanding (Weighted Average): 2009-2025

Historic Shares Outstanding (Weighted Average) for Lifecore Biomedical (LFCR) over the last 16 years, with May 2025 value amounting to $37.0 million.

  • Lifecore Biomedical's Shares Outstanding (Weighted Average) rose 21.21% to $37.0 million in Q2 2025 from the same period last year, while for May 2025 it was $37.0 million, marking a year-over-year increase of 21.21%. This contributed to the annual value of $37.0 million for FY2025, which is 21.21% up from last year.
  • According to the latest figures from Q2 2025, Lifecore Biomedical's Shares Outstanding (Weighted Average) is $37.0 million, which was down 0.00% from $37.0 million recorded in Q1 2025.
  • Lifecore Biomedical's 5-year Shares Outstanding (Weighted Average) high stood at $37.0 million for Q1 2025, and its period low was $29.3 million during Q1 2021.
  • In the last 3 years, Lifecore Biomedical's Shares Outstanding (Weighted Average) had a median value of $30.4 million in 2023 and averaged $31.7 million.
  • Data for Lifecore Biomedical's Shares Outstanding (Weighted Average) shows a peak YoY rose of 22.11% (in 2025) over the last 5 years.
  • Quarterly analysis of 5 years shows Lifecore Biomedical's Shares Outstanding (Weighted Average) stood at $29.5 million in 2021, then rose by 0.45% to $29.6 million in 2022, then grew by 2.46% to $30.3 million in 2023, then climbed by 1.90% to $30.9 million in 2024, then rose by 21.21% to $37.0 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $37.0 million in Q2 2025, compared to $37.0 million in Q1 2025 and $30.9 million in Q4 2024.